{{Rsnum
|rsid=2613514
|Gene=TMC6
|Chromosome=17
|position=78114437
|Orientation=plus
|GMAF=0.1455
|Gene_s=TMC6
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 86.6 | 13.4 | 0.0
| HCB | 66.4 | 28.5 | 5.1
| JPT | 60.2 | 35.4 | 4.4
| YRI | 52.1 | 41.1 | 6.8
| ASW | 47.4 | 47.4 | 5.3
| CHB | 66.4 | 28.5 | 5.1
| CHD | 61.1 | 34.3 | 4.6
| GIH | 57.4 | 36.6 | 5.9
| LWK | 46.4 | 46.4 | 7.3
| MEX | 79.3 | 20.7 | 0.0
| MKK | 57.1 | 37.8 | 5.1
| TSI | 82.4 | 17.6 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=3E-6
  |OR=20.12
  |ORtxt=[11.65-28.59] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}